Archive
Nov 12, 2003
Third Quarter 2003: Evotec OAI Reports 9-month Revenues up 20%, Positive EBITDA Sustained
Oct 22, 2003
Evotec OAI and Roche Sign Medicinal Chemistry Collaboration in Oncology
Oct 14, 2003
Evotec OAI and Biofrontera to Offer Natural Compounds for Drug Discovery Services
Sep 10, 2003
Evotec OAI and DeveloGen Announce a Strategic Drug Discovery and Development Alliance for Metabolic Diseases
Aug 12, 2003
Second Quarter 2003: Evotec OAI Reports Positive EBITDA in First Half
Aug 06, 2003
Evotec OAI Appoints Bernard Questier Chief Business Officer
Aug 01, 2003
Evotec Neurosciences and Takeda enter into drug discovery alliance in Alzheimer's disease
Jun 25, 2003
Evotec OAI Signs Medicinal Chemistry Agreement with Axxima Pharmaceuticals
May 15, 2003
Artesian Therapeutics Selects Evotec OAI as Drug Discovery Partner
May 08, 2003
First Quarter 2003: Evotec OAI Reports Good Start to 2003
Apr 10, 2003
Evotec OAI and Novartis Pharma AG Sign Lead Discovery Collaboration
Mar 25, 2003
Evotec OAI AG - Financial Results 2002, Sustained Growth in Challenging Markets
Mar 21, 2003
British Biotech to transfer research operations to Evotec OAI
Jan 30, 2003
Psychiatric Genomics Selects Evotec OAI as Their Strategic Chemistry Partner for Drug Discovery and Development
Jan 30, 2003
Evotec OAI's Preliminary Results 2002: Q4 Results Exceeding Expectations
Jan 30, 2003
Evotec OAI to Support Dynogen Pharmaceuticals in the Discovery and Development of Novel Pharmaceuticals
Jan 20, 2003
Euroscreen and Evotec OAI Partner GPCR Expertise - Companies Provide Comprehensive GPCR Screening, Product and Research Services
Jan 16, 2003
Evotec OAI Achieves Milestone with Clinical Advancement of Vertex Pharmaceuticals Compound
Jan 14, 2003
Evotec OAI Announces Drug Discovery Agreement with KeyNeurotek and the Institute of Medical Technology Magdeburg (IMTM)
Jan 08, 2003
Evotec OAI and Oxagen Initiate Drug Discovery Alliance